BIOL Biolase
- 0.017
- 0.0000.00%
Biolase News
Biolase: Q3 Earnings Snapshot
10-Q: Q3 2024 Earnings Report
United Kingdom Dental Lasers Market Outlook to 2033, Featuring Company Profiles for Biolase, Gigaa Optronics Technology, Dentsply Sirona, DEKA, Elexxion, FOTONA and Den-Mat Holdings
Sonendo Executes Asset Purchase Agreement to Acquire Biolase Assets
Sonendo Expands Portfolio and Pursues Damages Against Biolase
Express News | BIOLASE Lists Both Estimated Assets and Liabilities in the Range of $10,000,001- $50 Million - Court Filing
Express News | BIOLASE-Entered Into Asset Purchase Agreement With Sonendo, Which It Intends to Submit to the Court
Biolase Begins Chapter 11 Bankruptcy, Court-Supervised Sale
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
Express News | Sonendo - Evaluating Opportunity to Serve as "Stalking Horse Bidder" in Connection With BIOLASE's Potential Pending Bankruptcy Case Under Chapter 11
Express News | Sonendo Inc - on August 30, Unit of Co Entered Into Non-Binding Letter of Intent With BIOLASE, Inc
Biolase Is Maintained at Buy by Ascendiant Capital
Biolase Price Target Cut to $2.00/Share From $3.50 by Ascendiant Capital
United States Dental Equipment Market Forecast and Company Analysis 2024-2032 Featuring 3M, Straumann, Dentsply Sirona, ZimVie, Envista, Biolase, Young Innovations, Midmark, Takara Belmont, Ultradent
Seborrheic Keratosis Treatment Market Report 2024-2030, Featuring Comprehensive Profiles of Aclaris Therapeutics, Alma Lasers, BIOLASE, BioLineRx, DermBiont, Novartis and Pulse Biosciences
Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target
Biolase Analyst Ratings
Biolase GAAP EPS of -$0.08 Misses by $0.01, Revenue of $11.56M Misses by $1.94M
Biolase | 8-K: BIOLASE REPORTS 2024 SECOND QUARTER RESULTS; ACHIEVES 40% GROSS MARGIN AS GLOBAL CONSUMABLE SALES STRENGTHEN
Biolase | 10-Q: Q2 2024 Earnings Report
Analysis
Price Target
No Data
No Data